ARQT vs MUFG · rev $235.3M vs P/E 13, $159.03B cap
Arcutis Biotherapeutics Inc (ARQT) versus Mitsubishi UFJ Financial Group Inc ADR (MUFG) — a side-by-side from cached financials, not a winner call.
Arcutis Biotherapeutics Inc (ARQT) is a biotechnology company listed on US.
Mitsubishi UFJ Financial Group Inc ADR (MUFG) is a banks - diversified company listed on US.
Latest reported ARQT revenue for 2026-06-30 was $235.3M. Net income was $3.7M. ARQT currently screens at market cap $1.64B.
MUFG does not have a complete income-statement cache yet.
ARQT currently screens at market cap $1.64B. MUFG currently screens at market cap $159.03B and trailing P/E 12.6.
Not investment advice. Open the ARQT and MUFG stock pages for the full models.
Not investment advice.